The COVID pandemic illustrated how urgently we need antiviral medications capable of treating coronavirus infections. To aid ...

Recursion Pharmaceuticals RXRX is redefining the traditional model of drug discovery by harnessing the power of artificial ...

FDA's plan to phase out animal testing may hurt Charles River's revenues. The DCF model suggests that CRL presents an ...

While biopharmaceutical technologies have made substantial strides in treating diseases, drug research and development ...

The success of Vertex's opioid alternative Journavx could aid a group of biotechs that aim to take a similar path with NaV1.8 ...

Sigvotatug Vedotin is an ADC that targets integrin αvβ6-positive tumor cells. It has an engineered antibody that ensures high ...

A government initiative is developing advanced alternative testing methods that use no animals in the pharmaceutical ...

G protein-coupled receptors (GPCRs) represent the targets of more than 30% of the drugs currently on the market. However, ...

Thermo Fisher Scientific’s Accelerator™ Drug Development solutions, which integrate services for contract development and manufacturing organizations (CDMOs) and contract research organizations (CROs) ...

DARPA launched its “Quantum Benchmarking Initiative,” aiming to chart a path toward an industrially viable quantum computer ...

SandboxAQ, an artificial intelligence startup backed by Nvidia NVDA +0.48% Get Free Report and born from Alphabet's GOOG ...

Cancer remains one of the leading causes of mortality worldwide, driving an ongoing search for more effective and selective ...